IceCure Medical Ltd (ICCM) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $1.99 (0.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
ICCM vs Sector & Market
| Metric | ICCM | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | -49.8% | +22243.8% | +21.5% |
| P/E Ratio | -1.32 | 3.76 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $7M | $8M | $9M | 1 |
| 2027-12-31 | $12M | $14M | $16M | 1 |
| 2028-12-31 | $28M | $34M | $40M | 1 |
| 2029-12-31 | $45M | $55M | $64M | 1 |
| 2030-12-31 | $65M | $79M | $92M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.23 | $-0.18 | $-0.14 | 1 |
| 2027-12-31 | $-0.18 | $-0.15 | $-0.12 | 1 |
| 2028-12-31 | $-0.05 | $-0.04 | $-0.03 | 1 |
| 2029-12-31 | $0.06 | $0.08 | $0.10 | 1 |
| 2030-12-31 | $0.16 | $0.21 | $0.26 | 1 |
Frequently Asked Questions
What is the analyst consensus for ICCM?
The consensus among 1 analysts covering IceCure Medical Ltd (ICCM) is Buy with an average price target of $1.00.
What is the highest price target for ICCM?
The highest analyst price target for ICCM is $1.00.
What is the lowest price target for ICCM?
The lowest analyst price target for ICCM is $1.00.
How many analysts cover ICCM?
1 analysts have issued ratings for IceCure Medical Ltd in the past 12 months.
Is ICCM a buy or sell right now?
Based on 1 analyst ratings, ICCM has a consensus rating of Buy (2.00/5) with a -49.8% upside to the consensus target of $1.00.
What are the earnings estimates for ICCM?
Analysts estimate ICCM will report EPS of $-0.18 for the period ending 2026-12-31, with revenue estimated at $8M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.